Macrophages in Tissue Repair, Regeneration, and Fibrosis

Immunity

Volumn 44, Issue 3, 2016, Pages 450-462

  Wynn, Thomas A ^a   Vannella, Kevin M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROSIS; MACROPHAGE; MACROPHAGE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING; ANIMAL; CELL COMMUNICATION; CELL DIFFERENTIATION; HUMAN; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; FIBROSIS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; PHENOTYPE; REGENERATION; WOUND HEALING;

EID: 84960437624     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.02.015     Document Type: Review

References (129)

1. Alexander K.A., Flynn R., Lineburg K.E., Kuns R.D., Teal B.E., Olver S.D., Lor M., Raffelt N.C., Koyama M., Leveque L., et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. J. Clin. Invest. 2014, 124:4266-4280.
2. Antoniades C.G., Quaglia A., Taams L.S., Mitry R.R., Hussain M., Abeles R., Possamai L.A., Bruce M., McPhail M., Starling C., et al. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology 2012, 56:735-746.
3. Aurora A.B., Porrello E.R., Tan W., Mahmoud A.I., Hill J.A., Bassel-Duby R., Sadek H.A., Olson E.N. Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 2014, 124:1382-1392.
4. Baeck C., Wehr A., Karlmark K.R., Heymann F., Vucur M., Gassler N., Huss S., Klussmann S., Eulberg D., Luedde T., et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012, 61:416-426.
5. Baeck C., Wei X., Bartneck M., Fech V., Heymann F., Gassler N., Hittatiya K., Eulberg D., Luedde T., Trautwein C., Tacke F. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice. Hepatology 2014, 59:1060-1072.
6. Ben-Mordechai T., Holbova R., Landa-Rouben N., Harel-Adar T., Feinberg M.S., Abd Elrahman I., Blum G., Epstein F.H., Silman Z., Cohen S., Leor J. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J. Am. Coll. Cardiol. 2013, 62:1890-1901.
7. Berse B., Brown L.F., Van de Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 1992, 3:211-220.
8. Blériot C., Dupuis T., Jouvion G., Eberl G., Disson O., Lecuit M. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity 2015, 42:145-158.
9. Boehler R.M., Kuo R., Shin S., Goodman A.G., Pilecki M.A., Gower R.M., Leonard J.N., Shea L.D. Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype. Biotechnol. Bioeng. 2014, 111:1210-1221.
10. Borthwick L.A., Barron L., Hart K.M., Vannella K.M., Thompson R.W., Oland S., Cheever A., Sciurba J., Ramalingam T.R., Fisher A.J., Wynn T.A. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. 2016, 9:38-55.
11. Boulter L., Govaere O., Bird T.G., Radulescu S., Ramachandran P., Pellicoro A., Ridgway R.A., Seo S.S., Spee B., Van Rooijen N., et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 2012, 18:572-579.
12. Bourdonnay E., Zasłona Z., Penke L.R., Speth J.M., Schneider D.J., Przybranowski S., Swanson J.A., Mancuso P., Freeman C.M., Curtis J.L., Peters-Golden M. Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling. J. Exp. Med. 2015, 212:729-742.
13. Busch S.A., Hamilton J.A., Horn K.P., Cuascut F.X., Cutrone R., Lehman N., Deans R.J., Ting A.E., Mays R.W., Silver J. Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J. Neurosci. 2011, 31:944-953.
14. Campbell L., Saville C.R., Murray P.J., Cruickshank S.M., Hardman M.J. Local arginase 1 activity is required for cutaneous wound healing. J. Invest. Dermatol. 2013, 133:2461-2470.
15. Cao Q., Wang Y., Zheng D., Sun Y., Wang Y., Lee V.W., Zheng G., Tan T.K., Ince J., Alexander S.I., Harris D.C. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J. Am. Soc. Nephrol. 2010, 21:933-942.
16. Cao Q., Wang C., Zheng D., Wang Y., Lee V.W., Wang Y.M., Zheng G., Tan T.K., Yu D., Alexander S.I., et al. IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. J. Am. Soc. Nephrol. 2011, 22:1229-1239.
17. Cattin A.L., Burden J.J., Van Emmenis L., Mackenzie F.E., Hoving J.J., Garcia Calavia N., Guo Y., McLaughlin M., Rosenberg L.H., Quereda V., et al. Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves. Cell 2015, 162:1127-1139.
18. Chen F., Liu Z., Wu W., Rozo C., Bowdridge S., Millman A., Van Rooijen N., Urban J.F., Wynn T.A., Gause W.C. An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 2012, 18:260-266.
19. Chen G., Chen H., Wang C., Peng Y., Sun L., Liu H., Liu F. Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS ONE 2012, 7:e33626.
20. Chen C.C., Wang L., Plikus M.V., Jiang T.X., Murray P.J., Ramos R., Guerrero-Juarez C.F., Hughes M.W., Lee O.K., Shi S., et al. Organ-level quorum sensing directs regeneration in hair stem cell populations. Cell 2015, 161:277-290.
21. Chen L., Zhou X., Fan L.X., Yao Y., Swenson-Fields K.I., Gadjeva M., Wallace D.P., Peters D.J., Yu A., Grantham J.J., Li X. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J. Clin. Invest. 2015, 125:2399-2412.
22. Cho D.I., Kim M.R., Jeong H.Y., Jeong H.C., Jeong M.H., Yoon S.H., Kim Y.S., Ahn Y. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp. Mol. Med. 2014, 46:e70.
23. Chujo S., Shirasaki F., Kondo-Miyazaki M., Ikawa Y., Takehara K. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J. Cell. Physiol. 2009, 220:189-195.
24. Dal-Secco D., Wang J., Zeng Z., Kolaczkowska E., Wong C.H., Petri B., Ransohoff R.M., Charo I.F., Jenne C.N., Kubes P. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J. Exp. Med. 2015, 212:447-456.
25. Dalmas E., Toubal A., Alzaid F., Blazek K., Eames H.L., Lebozec K., Pini M., Hainault I., Montastier E., Denis R.G., et al. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat. Med. 2015, 21:610-618.
26. Das A., Sinha M., Datta S., Abas M., Chaffee S., Sen C.K., Roy S. Monocyte and macrophage plasticity in tissue repair and regeneration. Am. J. Pathol. 2015, 185:2596-2606.
27. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995.
28. De Nardo D., Labzin L.I., Kono H., Seki R., Schmidt S.V., Beyer M., Xu D., Zimmer S., Lahrmann C., Schildberg F.A., et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 2014, 15:152-160.
29. Deng B., Wehling-Henricks M., Villalta S.A., Wang Y., Tidball J.G. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 2012, 189:3669-3680.
30. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
31. Duffield J.S., Lupher M., Thannickal V.J., Wynn T.A. Host responses in tissue repair and fibrosis. Annu. Rev. Pathol. 2013, 8:241-276.
32. Ehling J., Bartneck M., Wei X., Gremse F., Fech V., Möckel D., Baeck C., Hittatiya K., Eulberg D., Luedde T., et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014, 63:1960-1971.
33. Epelman S., Lavine K.J., Beaudin A.E., Sojka D.K., Carrero J.A., Calderon B., Brija T., Gautier E.L., Ivanov S., Satpathy A.T., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40:91-104.
34. Epelman S., Lavine K.J., Randolph G.J. Origin and functions of tissue macrophages. Immunity 2014, 41:21-35.
35. Evans T.A., Barkauskas D.S., Myers J.T., Hare E.G., You J.Q., Ransohoff R.M., Huang A.Y., Silver J. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp. Neurol. 2014, 254:109-120.
36. Freytes D.O., Kang J.W., Marcos-Campos I., Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J. Cell. Biochem. 2013, 114:220-229.
37. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 2011, 12:1035-1044.
38. Gibbons M.A., MacKinnon A.C., Ramachandran P., Dhaliwal K., Duffin R., Phythian-Adams A.T., van Rooijen N., Haslett C., Howie S.E., Simpson A.J., et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184:569-581.
39. Godwin J.W., Pinto A.R., Rosenthal N.A. Macrophages are required for adult salamander limb regeneration. Proc. Natl. Acad. Sci. USA 2013, 110:9415-9420.
40. Goh Y.P., Henderson N.C., Heredia J.E., Red Eagle A., Odegaard J.I., Lehwald N., Nguyen K.D., Sheppard D., Mukundan L., Locksley R.M., Chawla A. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc. Natl. Acad. Sci. USA 2013, 110:9914-9919.
41. Gomez Perdiguero E., Klapproth K., Schulz C., Busch K., de Bruijn M., Rodewald H.R., Geissmann F. The Origin of Tissue-Resident Macrophages: When an Erythro-myeloid Progenitor Is an Erythro-myeloid Progenitor. Immunity 2015, 43:1023-1024.
42. Gundra U.M., Girgis N.M., Ruckerl D., Jenkins S., Ward L.N., Kurtz Z.D., Wiens K.E., Tang M.S., Basu-Roy U., Mansukhani A., et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014, 123:e110-e122.
43. Han M.S., Jung D.Y., Morel C., Lakhani S.A., Kim J.K., Flavell R.A., Davis R.J. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013, 339:218-222.
44. Harel-Adar T., Ben Mordechai T., Amsalem Y., Feinberg M.S., Leor J., Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl. Acad. Sci. USA 2011, 108:1827-1832.
45. Henderson N.C., Mackinnon A.C., Farnworth S.L., Kipari T., Haslett C., Iredale J.P., Liu F.T., Hughes J., Sethi T. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am. J. Pathol. 2008, 172:288-298.
46. Heredia J.E., Mukundan L., Chen F.M., Mueller A.A., Deo R.C., Locksley R.M., Rando T.A., Chawla A. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013, 153:376-388.
47. Hesse M., Cheever A.W., Jankovic D., Wynn T.A. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am. J. Pathol. 2000, 157:945-955.
48. Heymann F., Hammerich L., Storch D., Bartneck M., Huss S., Rüsseler V., Gassler N., Lira S.A., Luedde T., Trautwein C., Tacke F. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology 2012, 55:898-909.
49. Hos D., Bucher F., Regenfuss B., Dreisow M.L., Bock F., Heindl L.M., Eming S.A., Cursiefen C. IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages. Am. J. Pathol. 2016, 186:159-171.
50. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
51. Jay T.R., Miller C.M., Cheng P.J., Graham L.C., Bemiller S., Broihier M.L., Xu G., Margevicius D., Karlo J.C., Sousa G.L., et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J. Exp. Med. 2015, 212:287-295.
52. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van Rooijen N., MacDonald A.S., Allen J.E. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1288.
53. Jenkins S.J., Ruckerl D., Thomas G.D., Hewitson J.P., Duncan S., Brombacher F., Maizels R.M., Hume D.A., Allen J.E. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 2013, 210:2477-2491.
54. Kaviratne M., Hesse M., Leusink M., Cheever A.W., Davies S.J., McKerrow J.H., Wakefield L.M., Letterio J.J., Wynn T.A. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 2004, 173:4020-4029.
55. Khalil N., Bereznay O., Sporn M., Greenberg A.H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 1989, 170:727-737.
56. Kluth D.C. Pro-resolution properties of macrophages in renal injury. Kidney Int. 2007, 72:234-236.
57. Knipper J.A., Willenborg S., Brinckmann J., Bloch W., Maaß T., Wagener R., Krieg T., Sutherland T., Munitz A., Rothenberg M.E., et al. Interleukin-4 Receptor α Signaling in Myeloid Cells Controls Collagen Fibril Assembly in Skin Repair. Immunity 2015, 43:803-816.
58. Knuever J., Willenborg S., Ding X., Akyüz M.D., Partridge L., Niessen C.M., Brüning J.C., Eming S.A. Myeloid Cell-Restricted Insulin/IGF-1 Receptor Deficiency Protects against Skin Inflammation. J. Immunol. 2015, 195:5296-5308.
59. Korf-Klingebiel M., Reboll M.R., Klede S., Brod T., Pich A., Polten F., Napp L.C., Bauersachs J., Ganser A., Brinkmann E., et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat. Med. 2015, 21:140-149.
60. Kratochvill F., Neale G., Haverkamp J.M., Van de Velde L.A., Smith A.M., Kawauchi D., McEvoy J., Roussel M.F., Dyer M.A., Qualls J.E., Murray P.J. TNF Counterbalances the Emergence of M2 Tumor Macrophages. Cell Rep. 2015, 12:1902-1914.
61. Kroner A., Greenhalgh A.D., Zarruk J.G., Passos Dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
62. Lang R., Patel D., Morris J.J., Rutschman R.L., Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 2002, 169:2253-2263.
63. Lavine K.J., Epelman S., Uchida K., Weber K.J., Nichols C.G., Schilling J.D., Ornitz D.M., Randolph G.J., Mann D.L. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 2014, 111:16029-16034.
64. Lech M., Anders H.J. Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim. Biophys. Acta 2013, 1832:989-997.
65. Lemos D.R., Babaeijandaghi F., Low M., Chang C.K., Lee S.T., Fiore D., Zhang R.H., Natarajan A., Nedospasov S.A., Rossi F.M. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat. Med. 2015, 21:786-794.
66. London A., Itskovich E., Benhar I., Kalchenko V., Mack M., Jung S., Schwartz M. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 2011, 208:23-39.
67. Lörchner H., Pöling J., Gajawada P., Hou Y., Polyakova V., Kostin S., Adrian-Segarra J.M., Boettger T., Wietelmann A., Warnecke H., et al. Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart. Nat. Med. 2015, 21:353-362.
68. MacDonald K.P., Palmer J.S., Cronau S., Seppanen E., Olver S., Raffelt N.C., Kuns R., Pettit A.R., Clouston A., Wainwright B., et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010, 116:3955-3963.
69. Madala S.K., Pesce J.T., Ramalingam T.R., Wilson M.S., Minnicozzi S., Cheever A.W., Thompson R.W., Mentink-Kane M.M., Wynn T.A. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J. Immunol. 2010, 184:3955-3963.
70. Mauer J., Chaurasia B., Goldau J., Vogt M.C., Ruud J., Nguyen K.D., Theurich S., Hausen A.C., Schmitz J., Brönneke H.S., et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 2014, 15:423-430.
71. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
72. Mitchell S., Thomas G., Harvey K., Cottell D., Reville K., Berlasconi G., Petasis N.A., Erwig L., Rees A.J., Savill J., et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 2002, 13:2497-2507.
73. Mitchell C., Couton D., Couty J.P., Anson M., Crain A.M., Bizet V., Rénia L., Pol S., Mallet V., Gilgenkrantz H. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am. J. Pathol. 2009, 174:1766-1775.
74. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
75. Mounier R., Théret M., Arnold L., Cuvellier S., Bultot L., Göransson O., Sanz N., Ferry A., Sakamoto K., Foretz M., et al. AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 2013, 18:251-264.
76. Muñoz-Cánoves P., Serrano A.L. Macrophages decide between regeneration and fibrosis in muscle. Trends Endocrinol. Metab. 2015, 26:449-450.
77. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
78. Murray L.A., Chen Q., Kramer M.S., Hesson D.P., Argentieri R.L., Peng X., Gulati M., Homer R.J., Russell T., van Rooijen N., et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int. J. Biochem. Cell Biol. 2011, 43:154-162.
79. Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20.
80. Murray P.J., Rathmell J., Pearce E. SnapShot: Immunometabolism. Cell Metab. 2015, 22:190-190.e1.
81. Negash A.A., Ramos H.J., Crochet N., Lau D.T., Doehle B., Papic N., Delker D.A., Jo J., Bertoletti A., Hagedorn C.H., Gale M. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013, 9:e1003330.
82. Novak M.L., Weinheimer-Haus E.M., Koh T.J. Macrophage activation and skeletal muscle healing following traumatic injury. J. Pathol. 2014, 232:344-355.
83. Ostuni R., Kratochvill F., Murray P.J., Natoli G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 2015, 36:229-239.
84. Peiser L., Mukhopadhyay S., Gordon S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 2002, 14:123-128.
85. Pellicoro A., Aucott R.L., Ramachandran P., Robson A.J., Fallowfield J.A., Snowdon V.K., Hartland S.N., Vernon M., Duffield J.S., Benyon R.C., et al. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology 2012, 55:1965-1975.
86. Pesce J., Kaviratne M., Ramalingam T.R., Thompson R.W., Urban J.F., Cheever A.W., Young D.A., Collins M., Grusby M.J., Wynn T.A. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 2006, 116:2044-2055.
87. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., El Kasmi K.C., Smith A.M., Thompson R.W., Cheever A.W., Murray P.J., Wynn T.A. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
88. Ponomarev E.D., Veremeyko T., Barteneva N., Krichevsky A.M., Weiner H.L. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat. Med. 2011, 17:64-70.
89. Pradere J.P., Kluwe J., De Minicis S., Jiao J.J., Gwak G.Y., Dapito D.H., Jang M.K., Guenther N.D., Mederacke I., Friedman R., et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 2013, 58:1461-1473.
90. Ramachandran P., Pellicoro A., Vernon M.A., Boulter L., Aucott R.L., Ali A., Hartland S.N., Snowdon V.K., Cappon A., Gordon-Walker T.T., et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. USA 2012, 109:E3186-E3195.
91. Ramachandran P., Iredale J.P., Fallowfield J.A. Resolution of liver fibrosis: basic mechanisms and clinical relevance. Semin. Liver Dis. 2015, 35:119-131.
92. Rappolee D.A., Mark D., Banda M.J., Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988, 241:708-712.
93. Saclier M., Yacoub-Youssef H., Mackey A.L., Arnold L., Ardjoune H., Magnan M., Sailhan F., Chelly J., Pavlath G.K., Mounier R., et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells 2013, 31:384-396.
94. Said E.A., Dupuy F.P., Trautmann L., Zhang Y., Shi Y., El-Far M., Hill B.J., Noto A., Ancuta P., Peretz Y., et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 2010, 16:452-459.
95. Sandler N.G., Mentink-Kane M.M., Cheever A.W., Wynn T.A. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 2003, 171:3655-3667.
96. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
97. Shaked I., Hanna R.N., Shaked H., Chodaczek G., Nowyhed H.N., Tweet G., Tacke R., Basat A.B., Mikulski Z., Togher S., et al. Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation. Nat. Immunol. 2015, 16:1228-1234.
98. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., Kim K.W., Klein E., Kalchenko V., Bendel P., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
99. Shimokado K., Raines E.W., Madtes D.K., Barrett T.B., Benditt E.P., Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985, 43:277-286.
100. Shouval D.S., Biswas A., Goettel J.A., McCann K., Conaway E., Redhu N.S., Mascanfroni I.D., Al Adham Z., Lavoie S., Ibourk M., et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 2014, 40:706-719.
101. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
102. Soroosh P., Doherty T.A., Duan W., Mehta A.K., Choi H., Adams Y.F., Mikulski Z., Khorram N., Rosenthal P., Broide D.H., Croft M. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 2013, 210:775-788.
103. Stutchfield B.M., Antoine D.J., Mackinnon A.C., Gow D.J., Bain C.C., Hawley C.A., Hughes M.J., Francis B., Wojtacha D., Man T.Y., et al. CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure. Gastroenterology 2015, 149:1896-1909.e14.
104. Su S., Zhao Q., He C., Huang D., Liu J., Chen F., Chen J., Liao J.Y., Cui X., Zeng Y., et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat. Commun. 2015, 6:8523.
105. Suzuki T., Arumugam P., Sakagami T., Lachmann N., Chalk C., Sallese A., Abe S., Trapnell C., Carey B., Moritz T., et al. Pulmonary macrophage transplantation therapy. Nature 2014, 514:450-454.
106. Thomas J.A., Pope C., Wojtacha D., Robson A.J., Gordon-Walker T.T., Hartland S., Ramachandran P., Van Deemter M., Hume D.A., Iredale J.P., Forbes S.J. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 2011, 53:2003-2015.
107. Tonkin J., Temmerman L., Sampson R.D., Gallego-Colon E., Barberi L., Bilbao D., Schneider M.D., Musarò A., Rosenthal N. Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization. Mol. Ther. 2015, 23:1189-1200.
108. Ueno M., Maeno T., Nomura M., Aoyagi-Ikeda K., Matsui H., Hara K., Tanaka T., Iso T., Suga T., Kurabayashi M. Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L740-L752.
109. Ueno M., Maeno T., Nishimura S., Ogata F., Masubuchi H., Hara K., Yamaguchi K., Aoki F., Suga T., Nagai R., Kurabayashi M. Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages. Nat. Commun. 2015, 6:6332.
110. Vannella K.M., Barron L., Borthwick L.A., Kindrachuk K.N., Narasimhan P.B., Hart K.M., Thompson R.W., White S., Cheever A.W., Ramalingam T.R., Wynn T.A. Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. PLoS Pathog. 2014, 10:e1004372.
111. Warnatsch A., Ioannou M., Wang Q., Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 2015, 349:316-320.
112. Wehr A., Baeck C., Ulmer F., Gassler N., Hittatiya K., Luedde T., Neumann U.P., Trautwein C., Tacke F. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. PLoS ONE 2014, 9:e112327.
113. Westphalen K., Gusarova G.A., Islam M.N., Subramanian M., Cohen T.S., Prince A.S., Bhattacharya J. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 2014, 506:503-506.
114. Willenborg S., Lucas T., van Loo G., Knipper J.A., Krieg T., Haase I., Brachvogel B., Hammerschmidt M., Nagy A., Ferrara N., et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 2012, 120:613-625.
115. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 2004, 4:583-594.
116. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117:524-529.
117. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
118. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
119. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18:1028-1040.
120. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
121. Xiao X., Gaffar I., Guo P., Wiersch J., Fischbach S., Peirish L., Song Z., El-Gohary Y., Prasadan K., Shiota C., Gittes G.K. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc. Natl. Acad. Sci. USA 2014, 111:E1211-E1220.
122. Xu H., Zhu J., Smith S., Foldi J., Zhao B., Chung A.Y., Outtz H., Kitajewski J., Shi C., Weber S., et al. Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 2012, 13:642-650.
123. Xu J., Chi F., Guo T., Punj V., Lee W.N., French S.W., Tsukamoto H. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J. Clin. Invest. 2015, 125:1579-1590.
124. Yuk J.M., Kim T.S., Kim S.Y., Lee H.M., Han J., Dufour C.R., Kim J.K., Jin H.S., Yang C.S., Park K.S., et al. Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation. Immunity 2015, 43:80-91.
125. Yun M.H., Davaapil H., Brockes J.P. Recurrent turnover of senescent cells during regeneration of a complex structure. eLife 2015, 4. Published online May 5, 2015. 10.7554/eLife.05505.
126. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
127. Zhang M.Z., Yao B., Yang S., Jiang L., Wang S., Fan X., Yin H., Wong K., Miyazawa T., Chen J., et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 2012, 122:4519-4532.
128. Zheng D., Wang Y., Cao Q., Lee V.W., Zheng G., Sun Y., Tan T.K., Wang Y., Alexander S.I., Harris D.C. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus. Nephron, Exp. Nephrol. 2011, 118:e87-e99.
129. Zigmond E., Bernshtein B., Friedlander G., Walker C.R., Yona S., Kim K.W., Brenner O., Krauthgamer R., Varol C., Müller W., Jung S. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 2014, 40:720-733.